Skip to main navigation menu Skip to main content Skip to site footer

Viewpoint

Vol. 150 No. 3334 (2020)

Obesity, inflammation and COVID-19

  • Alberto Beretta
DOI
https://doi.org/10.4414/smw.2020.20349
Cite this as:
Swiss Med Wkly. 2020;150:w20349
Published
19.08.2020

References

  1. Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, et al.; COVID Outcomes HCL Consortium and Lille COVID–Obesity Study Group. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8(7):562–4. doi:.https://doi.org/10.1016/S2213-8587(20)30160-1
  2. Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020;395(10236):1544–5. doi:.https://doi.org/10.1016/S0140-6736(20)31024-2
  3. Beretta A. Unexpected liaisons between old cytokines and new deadly virus. Swiss Med Wkly. 2020;150:w20315. doi:.https://doi.org/10.4414/smw.2020.20315
  4. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. doi:.https://doi.org/10.1038/nri2921